Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma

被引：7

作者：

Iwamoto, Hideki ^{[1
,2
]}

Shimose, Shigeo ^{[1
]}

Niizeki, Takashi ^{[1
]}

Koga, Hironori ^{[1
]}

Torimura, Takuji ^{[1
]}

机构：

[1] Kurume Univ, Div Gastroenterol, Dept Med, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan

[2] Iwamoto Internal Med Clin, Kitakyushu, Fukuoka, Japan

来源：

CLINICAL AND MOLECULAR HEPATOLOGY | 2022年 / 28卷 / 03期

关键词：

Hepatocellular carcinoma; Atezolizumab; Bevacizumab; Tumor marker;

D O I：

10.3350/cmh.2022.0047

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：575 / 579

页数：6

共 7 条

[1] Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice [J].

Ando, Yuwa ;

Kawaoka, Tomokazu ;

Kosaka, Masanari ;

Shirane, Yuki ;

Johira, Yusuke ;

Miura, Ryoichi ;

Murakami, Serami ;

Yano, Shigeki ;

Amioka, Kei ;

Naruto, Kensuke ;

Kosaka, Yumi ;

Uchikawa, Shinsuke ;

Kodama, Kenichiro ;

Fujino, Hatsue ;

Nakahara, Takashi ;

Ono, Atsushi ;

Murakami, Eisuke ;

Yamauchi, Masami ;

Okamoto, Wataru ;

Takahashi, Shoichi ;

Imamura, Michio ;

Chayama, Kazuaki ;

Aikata, Hiroshi .

CANCERS, 2021, 13 (16)

[2] IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma. [J].

Finn, Richard S. ;

Ducreux, Michel ;

Qin, Shukui ;

Galle, Peter R. ;

Zhu, Andrew X. ;

Ikeda, Masafumi ;

Kim, Tae-You ;

Xu, Derek-Zhen ;

Verret, Wendy ;

Liu, Juan ;

Grossman, William ;

Cheng, Ann-Lii .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[3] Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline [J].

Gordan, John D. ;

Kennedy, Erin B. ;

Abou-Alfa, Ghassan K. ;

Beg, Muhammad Shaalan ;

Brower, Steven T. ;

Gade, Terence P. ;

Goff, Laura ;

Gupta, Shilpi ;

Guy, Jennifer ;

Harris, William P. ;

Iyer, Renuka ;

Jaiyesimi, Ishmael ;

Jhawer, Minaxi ;

Karippot, Asha ;

Kaseb, Ahmed O. ;

Kelley, R. Kate ;

Knox, Jennifer J. ;

Kortmansky, Jeremy ;

Leaf, Andrea ;

Remak, William M. ;

Shroff, Rachna T. ;

Sohal, Davendra P. S. ;

Taddei, Tamar H. ;

Venepalli, Neeta K. ;

Wilson, Andrea ;

Zhu, Andrew X. ;

Rose, Michal G. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) :4317-+

[4] Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice [J].

Iwamoto, Hideki ;

Shimose, Shigeo ;

Noda, Yu ;

Shirono, Tomotake ;

Niizeki, Takashi ;

Nakano, Masahito ;

Okamura, Shusuke ;

Kamachi, Naoki ;

Suzuki, Hiroyuki ;

Sakai, Miwa ;

Kajiwara, Akira ;

Itano, Satoshi ;

Tanaka, Masatoshi ;

Yamaguchi, Taizo ;

Kuromatsu, Ryoko ;

Koga, Hironori ;

Torimura, Takuji .

CANCERS, 2021, 13 (11)

[5] Management of Hepatocellular Carcinoma in Japan: JS']JSH Consensus Statements and Recommendations 2021 Update [J].

Kudo, Masatoshi ;

Kawamura, Yusuke ;

Hasegawa, Kiyoshi ;

Tateishi, Ryosuke ;

Kariyama, Kazuya ;

Shiina, Shuichiro ;

Toyoda, Hidenori ;

Imai, Yasuharu ;

Hiraoka, Atsushi ;

Ikeda, Masafumi ;

Izumi, Namiki ;

Moriguchi, Michihisa ;

Ogasawara, Sadahisa ;

Minami, Yasunori ;

Ueshima, Kazuomi ;

Murakami, Takamichi ;

Miyayama, Shiro ;

Nakashima, Osamu ;

Yano, Hirohisa ;

Sakamoto, Michiie ;

Hatano, Etsuro ;

Shimada, Mitsuo ;

Kokudo, Norihiro ;

Mochida, Satoshi ;

Takehara, Tetsuo .

LIVER CANCER, 2021, 10 (03) :181-223

[6] Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial [J].

Kudo, Masatoshi ;

Ueshima, Kazuomi ;

Chiba, Yasutaka ;

Ogasawara, Sadahisa ;

Obi, Shuntaro ;

Izumi, Namiki ;

Aikata, Hiroshi ;

Nagano, Hiroaki ;

Hatano, Etsuro ;

Sasaki, Yutaka ;

Hino, Keisuke ;

Kumada, Takashi ;

Yamamoto, Kazuhide ;

Imai, Yasuharu ;

Iwadou, Shouta ;

Ogawa, Chikara ;

Okusaka, Takuji ;

Kanai, Fumihiko ;

Arai, Yasuaki .

LIVER CANCER, 2019, 8 (06) :505-519

[7]

Llovet JM, 2020, J HEPATOL, V72, P288, DOI 10.1016/j.jhep.2019.09.026

← 1 →